Co-Diagnostics Inc (CODX) Stock Price, Quote & News

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, hum...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 438 1036

Website: co-dx.com

Address:

2401 S. Foothill Drive, Suite D, Salt Lake City, United States

SmallPhish Aug. 24 at 5:57 PM

$CODX The CEO really needs dumb people to buy the new shares being dumped by Maxim Group. Company needs money to pay huge salaries to family

0 · Reply

MajorGainz7 Aug. 24 at 2:26 PM

$CODX looking good

0 · Reply

Antiquarian Aug. 24 at 2:21 PM

$CODX https://lnkd.in/p/eCXh7zmA

0 · Reply

SmallPhish Aug. 24 at 1:05 PM

$CODX Maxim Group is sneaking up the price on low volume hoping to sell to naive whales

1 · Reply

Antiquarian Aug. 24 at 12:54 PM

$CODX Malodorous Methane Monday is about to begin. Nice to see the price move up a little. Lets see some news👍

1 · Reply

FTTHolding Aug. 24 at 12:18 PM

$GOVX $CODX $CNEY Waiting for 100% runner

0 · Reply

SmallPhish Aug. 24 at 10:15 AM

$CODX Maxim Group was hired by this company to sell $7.9 million worth of shares. The company is not profitable and resorts to selling new shares to avoid bankruptcy

0 · Reply

MajorGainz7 Aug. 24 at 10:03 AM

$CODX 1.40 + today ?

0 · Reply

LDNGreenPot Aug. 24 at 8:32 AM

$CODX Investors are to be cautions of pumpers on this specific stock and, DO YOUR RESEARCH BEFORE INVESTING!!! -

0 · Reply

Allyofall2 Aug. 23 at 9:09 PM

$CODX un-ordinary, innovative, proven technologies. Uniquely positioned to rapidly progress forward into decade + mission statements.

0 · Reply

Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event

CODX

Aug 13, 2026, 4:30 PM EDT - 10 days ago

Co-Diagnostics Earnings Call Transcript: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 10 days ago

Co-Diagnostics Earnings release: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 10 days ago

Co-Diagnostics Quarterly report: Q2 2026

Aug 13, 2026, 4:01 PM EDT - 10 days ago

Co-Diagnostics Reports Second Quarter 2026 Financial Results

CODX

2026-08-06T13:36:10.000Z - 18 days ago

Co-Diagnostics submits FDA 510(k) premarket notification for Co-Dx PCR Flu test

CODX

Aug 6, 2026, 9:30 AM EDT - 18 days ago

Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test

CODX

Jul 30, 2026, 9:00 AM EDT - 25 days ago

Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast

CODX

2026-07-28T12:10:57.000Z - 27 days ago

Co-Diagnostics joint venture CoSara provides ebola test kits for India studies

CODX

Jul 28, 2026, 8:00 AM EDT - 27 days ago

Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies

CODX

Jul 22, 2026, 9:00 AM EDT - 4 weeks ago

Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform

CODX

Jul 21, 2026, 8:00 AM EDT - 4 weeks ago

Co-Diagnostics Proxy statement: Proxy filing

2026-07-16T13:05:10.000Z - 5 weeks ago

Co-Diagnostics appoints Wes Lindsey as Chief Scientific Officer

CODX

Jul 16, 2026, 9:00 AM EDT - 5 weeks ago

Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer

CODX

Jul 10, 2026, 8:00 AM EDT - 6 weeks ago

Co-Diagnostics Proxy statement: Proxy filing

Jul 8, 2026, 9:00 AM EDT - 6 weeks ago

Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand

CODX

Jul 1, 2026, 9:00 AM EDT - 7 weeks ago

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test

CODX

Jun 25, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

CODX

2026-06-11T13:08:40.000Z - 2 months ago

Co-Diagnostics signs distribution agreement for CO-Dx PCR Pro in Mexico

CODX

Jun 11, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

CODX

2026-06-02T14:52:18.000Z - 2 months ago

Co-Diagnostics announces continued progress in Ebola PCR development program

CODX

2026-06-02T14:07:28.000Z - 2 months ago

Co-Diagnostics trading halted, volatility trading pause

CODX

2026-06-02T13:54:50.000Z - 2 months ago

Co-Diagnostics trading resumes

CODX

Jun 2, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

CODX

2026-05-28T21:18:09.000Z - 3 months ago

Co-Diagnostics files to sell 4.94M shares of common stock for holders

CODX

May 28, 2026, 8:00 AM EDT - 3 months ago

Co-Diagnostics Registration statement: Registration filing

2026-05-27T15:15:44.000Z - 3 months ago

Co-Diagnostics trading halted, volatility trading pause

CODX

2026-05-27T15:08:07.000Z - 3 months ago

Co-Diagnostics trading resumes

CODX

2026-05-26T14:04:46.000Z - 3 months ago

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

CODX

May 26, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

CODX

May 19, 2026, 10:54 PM EDT - 3 months ago

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CODX

2026-05-19T13:16:13.000Z - 3 months ago

Co-Diagnostics develops ebola assay strategy after recent global outbreak alert

CODX

May 19, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

CODX

2026-05-14T21:49:36.000Z - 3 months ago

Co-Diagnostics reports Q1 EPS ($4.06) vs. ($7.05) last year

CODX

May 14, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Quarterly report: Q1 2026

May 14, 2026, 4:01 PM EDT - 3 months ago

Co-Diagnostics Reports First Quarter 2026 Financial Results

CODX

May 14, 2026, 4:00 PM EDT - 3 months ago

Co-Diagnostics Slides: Investor presentation

2026-05-12T20:55:31.000Z - 3 months ago

Co-Diagnostics files $150M mixed securities shelf

CODX

May 12, 2026, 8:00 AM EDT - 3 months ago

Co-Diagnostics Registration statement: Registration filing

2026-05-08T15:28:11.000Z - 3 months ago

Co-Diagnostics’ joint venture with CoMira finalizes facility lease agreement

CODX

May 8, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

CODX

Apr 30, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

CODX

Apr 16, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

CODX

Apr 14, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

CODX

Apr 9, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

CODX

Mar 31, 2026, 4:30 PM EDT - 5 months ago

Co-Diagnostics Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 5 months ago

Co-Diagnostics Annual report: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 5 months ago

Co-Diagnostics Earnings release: Q4 2025

Mar 31, 2026, 4:01 PM EDT - 5 months ago

Co-Diagnostics Reports Full Year 2025 Financial Results

CODX

Mar 25, 2026, 8:00 AM EDT - 5 months ago

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

CODX

2026-03-20T12:11:57.000Z - 5 months ago

Co-Diagnostics to expand commercial, distribution territory across South Asia

CODX

Mar 20, 2026, 8:00 AM EDT - 5 months ago

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

CODX

Mar 17, 2026, 9:00 AM EDT - 5 months ago

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

CODX

Mar 16, 2026, 9:00 AM EDT - 5 months ago

Co-Diagnostics to Present at Medical Korea 2026

CODX

Mar 12, 2026, 9:00 AM EDT - 5 months ago

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

CODX

Mar 10, 2026, 9:00 AM EDT - 5 months ago

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

CODX

Feb 9, 2026, 9:00 AM EST - 7 months ago

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

CODX

Feb 5, 2026, 9:00 AM EST - 7 months ago

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

CODX

Feb 4, 2026, 9:00 AM EST - 7 months ago

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

CODX

2026-01-23T14:10:52.000Z - 7 months ago

Co-Diagnostics cut to Hold at Maxim on Nasdaq delisting

CODX

Jan 12, 2026, 9:00 AM EST - 8 months ago

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

CODX

Dec 30, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Announces Reverse Stock Split

CODX

Dec 29, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

CODX

Dec 18, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

CODX

Dec 17, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

CODX

Dec 9, 2025, 9:00 AM EST - 9 months ago

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

CODX

Dec 8, 2025, 12:36 PM EST - 9 months ago

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

CODX

Nov 20, 2025, 9:00 AM EST - 9 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

CODX

Nov 18, 2025, 9:00 AM EST - 9 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

CODX

Nov 13, 2025, 4:30 PM EST - 10 months ago

Co-Diagnostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Co-Diagnostics Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Co-Diagnostics Earnings release: Q3 2025

Nov 13, 2025, 4:01 PM EST - 10 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results

CODX

Nov 10, 2025, 7:00 AM EST - 10 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Nov 5, 2025, 11:00 AM EST - 10 months ago

Co-Diagnostics Transcript: Fireside Chat

Nov 5, 2025, 9:00 AM EST - 10 months ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

CODX

Nov 3, 2025, 9:00 AM EST - 10 months ago

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

CODX

Oct 31, 2025, 9:00 AM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

CODX

Oct 31, 2025, 8:00 AM EDT - 10 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Oct 30, 2025, 1:57 PM EDT - 10 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

CODX

Oct 29, 2025, 12:51 PM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

CODX

Oct 28, 2025, 9:33 AM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

CODX

Oct 22, 2025, 8:30 AM EDT - 10 months ago

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

CODX

Oct 16, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

CODX

Oct 13, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

CODX

SmallPhish Aug. 24 at 5:57 PM

$CODX The CEO really needs dumb people to buy the new shares being dumped by Maxim Group. Company needs money to pay huge salaries to family

0 · Reply

MajorGainz7 Aug. 24 at 2:26 PM

$CODX looking good

0 · Reply

Antiquarian Aug. 24 at 2:21 PM

$CODX https://lnkd.in/p/eCXh7zmA

0 · Reply

SmallPhish Aug. 24 at 1:05 PM

$CODX Maxim Group is sneaking up the price on low volume hoping to sell to naive whales

1 · Reply

Antiquarian Aug. 24 at 12:54 PM

$CODX Malodorous Methane Monday is about to begin. Nice to see the price move up a little. Lets see some news👍

1 · Reply

FTTHolding Aug. 24 at 12:18 PM

$GOVX $CODX $CNEY Waiting for 100% runner

0 · Reply

SmallPhish Aug. 24 at 10:15 AM

$CODX Maxim Group was hired by this company to sell $7.9 million worth of shares. The company is not profitable and resorts to selling new shares to avoid bankruptcy

0 · Reply

MajorGainz7 Aug. 24 at 10:03 AM

$CODX 1.40 + today ?

0 · Reply

LDNGreenPot Aug. 24 at 8:32 AM

$CODX Investors are to be cautions of pumpers on this specific stock and, DO YOUR RESEARCH BEFORE INVESTING!!! -

0 · Reply

Allyofall2 Aug. 23 at 9:09 PM

$CODX un-ordinary, innovative, proven technologies. Uniquely positioned to rapidly progress forward into decade + mission statements.

0 · Reply

SmallPhish Aug. 22 at 3:40 PM

$CODX Can Dwight pay the bills this quarter? Down to $3.5 million and trying to sell $7.9 million in new shares

2 · Reply

SmallPhish Aug. 21 at 9:41 PM

$CODX What big business deals did the Egan family accomplish this week?

0 · Reply

coolmate25 Aug. 21 at 8:06 PM

$CODX Well overall not a bad performance today other than few cheapies needed mcmeal for their families after earning a couple of pennies. Hopefully it will get back on track next week , happy weekend.

0 · Reply

Antiquarian Aug. 21 at 7:58 PM

$CODX As ‘Flatulent Friday’ comes to a close, let’s all hope for good things to come on this ticker in the coming weeks.

0 · Reply

SmallPhish Aug. 21 at 7:33 PM

$CODX How many shares did Millenium sell today to fund this business with no profits

2 · Reply

coolmate25 Aug. 21 at 3:42 PM

$CODX Armistice Capital, LLC filed a 13DG report with the Securities and Exchange Commission, disclosing the acquisition of 559,706 shares of Co-Diagnostics Inc (NASDAQ:CODX) at a price of $3.10 per share. This transaction represents a new position for the firm, marking its initial foray into the molecular diagnostics company. Well not today but someday , they have to take it above $3.10 , let's see and Good luck for us .

1 · Reply

SmallPhish Aug. 21 at 3:22 PM

$CODX Market Cap is $7.19 million

0 · Reply

coolmate25 Aug. 21 at 2:54 PM

$CODX Investments coming in at this point when necessary, hopefully soon it will be back on track next week and remember don't be bothered by parasites.

0 · Reply

CoffeeRocks Aug. 21 at 2:37 PM

$CODX $BTAI $INO Careful Shorts will take this to .7$S .8$S

1 · Reply

coolmate25 Aug. 21 at 2:21 PM

$CODX Hmmmm some MFS fcked up but again to buy on dip .

0 · Reply

coolmate25 Aug. 21 at 2:05 PM

$CODX

0 · Reply

SmallPhish Aug. 21 at 1:55 PM

$CODX Shrink company footprint from 3 rental buildings to 1 rental

0 · Reply

Market Cap	7.57M
Revenue (ttm)	620,000.00
Net Income (ttm)	-46.90M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-7,564.52%
Debt to Equity Ratio	0.00

Volume	250,393
Avg Vol	511,940
Day's Range	N/A - N/A
Shares Out	6.25M
Stochastic %K	43%
Beta	2.87
Analysts	Sell
Price Target	$4.00